A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease

Clinical trial NCT00446550 · COMPLETED

Trial details

NCT number: NCT00446550
Sponsor: Amicus Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gaucher Disease Type 1 Gaucher Disease Gaucher Disease, Type 1

Start date: 2008-06-11
Primary completion: 2009-08-20
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.